XTX Topco’s Sanara MedTech SMTI Stock Holding History

XTX Topco’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,602	Closed	-$217K	–	4668
2026 Q1	$217K	Buy	+12,602	New	+$259K	﹤0.01%	2781

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

XTX Topco's SMTI Position: Q2 2026 in Review

XTX Topco sold out of Sanara MedTech (SMTI) in Q2 2026, closing a stake of 12,602 shares — an estimated $217K sold.

XTX Topco first reported a position in SMTI in Q1 2026 and held it in 1 quarter. The position peaked at $217K in Q1 2026. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

XTX Topco reported no remaining Sanara MedTech position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 12,602 Sanara MedTech shares in Q2 2026, an estimated $217K.
XTX Topco first reported a position in Sanara MedTech in Q1 2026 and held it in 1 quarter.
XTX Topco's Sanara MedTech position peaked at $217K in Q1 2026.
74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.